Home Visit
Upload
.png)
Maternal Screen (Triple Test) Second Trimester Test in Juhu
50+ booked in last 3 days
No special precautions
Sample Type
Blood
Recommended for
Female
Report
Within 24 Hours
Blood test at Home
NABL & CAP Accredited Labs
Accurate & Quality Test Reports
Trusted by Leading Doctors & Hospitals
Overview
Triple marker test is basically a screening blood test that is used to screen pregnant women for potential congenital defects in foetus i.e., neural tube defects, Down syndrome and Trisomy 18 in the unborn child. Primarily three hormones are measured in mother’s blood (thus known as the Triple Marker test). This test can be performed any time between 14 to 22.6 weeks of pregnancy.
This test only determines the possibility that the fetus will have chromosomal abnormalities. This is because it is simply a predictive test. It is not a conclusive test. The triple marker test is named as such because it looks for alpha-fetoprotein, beta-hCG, and unconjugated estriol.
The triple marker test is essentially a blood screening procedure. It is used to check pregnant women for possible congenital problems in the fetus. These could be neural tube defects, Down syndrome, and Trisomy 18. The mother's blood is mostly tested for three hormones (thus known as the Triple Marker test). The pregnancy can be between 14 and 22.6 weeks at the time of this test.
Written by: Dr. Jasmin Surana, MD Biochemistry, Dept. of Biochemistry
Maternal Screen (Triple Test) Second Trimester Test Price in Juhu
Metropolis Healthcare is a leading diagnostics centre and pathology lab in India equipped with the latest state-of-the-art technologies that provides the Maternal Screen (Triple Test) Second Trimester Test with a clear pricing structure
The price of Maternal Screen (Triple Test) Second Trimester Test in Juhu is ₹ 3,070
We are committed to deliver accurate and quality results from the best labs in India with complete transparency regarding test cost and turnaround time. No matter where you are, we strive to offer patients high-quality service that is affordable and accessible.
Frequently Asked Questions
Triple marker tests identify pregnancies that have a high risk of babies having the following abnormalities:
- Trisomy 21 (Down’s syndrome)
- Trisomy 18 (Edward syndrome)
- Neural tube defects
These tests are NOT diagnostic tests. Your doctor will order a confirmatory test when the screening test is positive (high risk)
This test is conducted between the 14th and 18th weeks of pregnancy.
The test is often most recommended under the following scenarios
- Age of the pregnant woman is above 35
- Dual Marker tests were abnormal
- Birth defects in the family
- The pregnant woman is diabetic and under insulin medication
- If it is suspected that the pregnant woman was exposed to a high dose of radiation
- A viral infection during pregnancy
AFP (Alpha-fetoprotein) AFP or alpha fetoprotein is made by the foetal liver and some amount of this substance gets into the mother’s blood. Higher levels of AFP are seen in Neural tube defects and levels are decreased in Down syndrome and Edward syndrome. What if I am a man and have high AFP level? What if I am a non-pregnant woman and have high AFP level? In men, non-pregnant women, and children, AFP in the blood can mean certain types of cancer, especially cancer of the testicles, ovaries, stomach, pancreas, or liver are present. uE3 (Unconjugated Estriol) Estriol is a hormone produced by the placenta, using ingredients made by the fetal liver and adrenal glands. In pregnancies with Down Syndrome or Edward Syndrome, it is observed that the Estriol levels are reduced.
Ratings & Reviews (0)
Why Metropolis?
Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.
We offer a comprehensive range of 4000+ clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.
WhatsApp